🔗 Permalink

Inventor profile of:

Bruce D. Hammock

City:

Davis, California

Country:

United States

Published Applications:

Last publication date:

2026-05-14

Top Assignees for applications by Bruce D. Hammock

The entities that hold a legal rights for patent applications filed by inventor Hammock Bruce D.:

The Regents of the University of California 46 Oakland, CA United States
REGENTS OF THE UNIVERSITY OF CALIFORNIA 5 Oakland, CA United States
Burnham Institute for Medical Research 2 La Jolla, CA United States
Chiba University 2 Chiba, Japan
The Trustees of Dartmouth College 2 Hanover, NH United States
The Regents of the University of California Office of Technology Transfer 2 Oakland, CA United States
REGENTS OF THE UNIVERSITY OF CALIFORNIA Office of Technology Transfer 2 Oakland, CA United States
Eicosis, LLC 2 Davis, CA United States
The Regents Of The University Of California Office of Technology, 1 Oakland, CA United States
United States as represented by the Department of Veterans Affairs 1 Washington, DC United States
The Regents of te University of California 1 Oakland, CA United States
The Burnham Institute for Medical Research 1 LaJolla, CA United States
United States of America, as Represented by Secretary of Health and Human Services 1 Rockville, MD United States
Goethe-University Frankfurt 1 Frankfurt, Germany
Texas A&M University 1 College Station, TX United States
Sanford-Burnham Medical Research Institute 1 La Jolla, CA United States
The Regents of the University of California 1 Berkeley, CA United States
Massachusetts Eye and Ear Infirmary 1 Boston, MA United States
MEDICAL COLLEGE OF GEORGIA 1 Augusta, GA United States
Arete Therapeutics 1 Hayward, CA United States
The United States of America as represented by the Secretary of the Department of Health and Human Services 1 Washington, DC United States
The Government of the U.S, as represented by the Secretary of the Dept. of Health & Human Services 1 Rockville, MD United States
Trustees of Dartmouth College 1 Hanover, NH United States
GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUM 1 Rockville, MD United States

Recent patent applications by Hammock Bruce D.

Bruce D. Hammock from Davis, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260130877A1

Human necessities

TREATMENT OF NEURODEVELOPMENTAL DISORDERS

#2 | 2025-06-26

US20250205217A1

Human necessities

METHODS OF IMPROVING CANCER IMMUNOTHERAPY

#3 | 2024-01-25

US20240024302A1

Human necessities

SOLUBLE EPOXIDE HYDROLASE (sEH) INHIBITORS AND DUAL COX/sEH INHIBITORS FOR THE TREATMENT OF ARRHYTHMOGENIC CARDIOMYOPATHY

#4 | 2023-09-28

US20230301949A1

Human necessities

TREATMENT OF NEURODEVELOPMENTAL DISORDERS

#5 | 2022-06-30

US20220202744A1

Human necessities

METHODS OF TREATING MENTAL DISORDERS

#6 | 2022-06-02

US20220169708A1

Chemistry; metallurgy

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

#7 | 2021-12-23

US20210395202A1

Chemistry; metallurgy

Orally available sEH/PDE4 dual inhibitors

#8 | 2021-06-17

US20210179549A1

Chemistry; metallurgy

Co-crystal of sorafenib derivatives and process for preparation thereof

#9 | 2021-06-03

US20210161881A1

Human necessities

Methods of inhibiting formation of alpha synuclein aggregates

#10 | 2021-05-20

US20210145891A1

Human necessities

Methods of improving cell-based therapy

#11 | 2020-07-23

US20200231659A1

Chemistry; metallurgy

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

#12 | 2020-06-25

US20200197368A1

Human necessities

Methods of improving cancer chemotherapy

#13 | 2020-01-02

US20200000755A1

Human necessities

TREATMENT OF INFLAMMATORY DISORDERS IN NON-HUMAN MAMMALS

#14 | 2019-12-05

US20190365733A1

Human necessities

Methods of improving cell-based therapy

#15 | 2019-05-02

US20190125696A1

Human necessities

Methods of treating mental disorders

#16 | 2018-11-15

US20180325860A1

Human necessities

Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

#17 | 2018-07-19

US20180200244A1

Human necessities

Methods of improving cell-based therapy

#18 | 2018-07-05

US20180185309A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATING NEPHROPATHY

#19 | 2018-05-10

US20180125803A1

Human necessities

Methods of inhibiting pain

#20 | 2017-06-22

US20170174665A1

Chemistry; metallurgy

Potent soluble epdxide hydrolase inhibitors

#21 | 2016-07-21

US20160206605A1

Human necessities

Compounds and methods for inhibiting Cif virulence factor

#22 | 2016-07-14

US20160200683A1

Chemistry; metallurgy

ACYL PIPERIDINE INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

#23 | 2016-01-14

US20160008342A1

Human necessities

METHODS OF IMPROVING CELL-BASED THERAPY

#24 | 2015-05-14

US20150132408A1

Human necessities

Sorafenib derivatives as p21 inhibitors

#25 | 2015-03-05

US20150065540A1

Chemistry; metallurgy

Substituted piperidines as soluble epdxide hydrolase inhibitors

#26 | 2015-02-12

US20150045389A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR INHIBITING CIF VIRULENCE FACTOR

#27 | 2015-01-15

US20150017267A1

Human necessities

Treatment of inflammatory disorders in non-human mammals

#28 | 2015-01-08

US20150011586A1

Chemistry; metallurgy

Acyl piperidine inhibitors of soluble epoxide hydrolase

#29 | 2014-03-27

US20140088156A1

Chemistry; metallurgy

Sorafenib derivatives as sEH inhibitors

#30 | 2014-02-06

US20140038923A1

Chemistry; metallurgy

Pyrazole inhibitors of COX-2 and sEH

#31 | 2013-10-17

US20130274476A1

Chemistry; metallurgy

Conformationally restricted urea inhibitors of soluble epoxide hydrolase

#32 | 2013-06-06

US20130143925A1

Chemistry; metallurgy

Acyl piperidine inhibitors of soluble epoxide hydrolase

#33 | 2013-05-30

US20130137726A1

Chemistry; metallurgy

Conformationally restricted urea inhibitors of soluble epoxide hydrolase

#34 | 2013-03-14

US20130065936A1

Chemistry; metallurgy

MODULATION OF BIOACTIVE EPOXY-FATTY ACID LEVELS BY PHOSPHODIESTERASE INHIBITORS

#35 | 2013-02-21

US20130045172A1

Human necessities

USE OF CIS-EPOXYEICOSATRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO TREAT CONDITIONS MEDIATED BY PBR, CB2, and NK2 RECEPTORS

#36 | 2012-02-23

US20120046251A1

Human necessities

INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO INHIBIT OR PREVENT NIACIN-INDUCED FLUSHING

#37 | 2011-11-03

US20110269831A1

Human necessities

Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids

#38 | 2011-10-06

US20110245331A1

Human necessities

INHIBITORS OF EPOXIDE HYDROLASES FOR THE TREATMENT OF HYPERTENSION

#39 | 2011-09-22

US20110230504A1

Human necessities

ALLEVIATING DISORDERS WITH COMBINING AGENTS THAT INCREASE EPOXYGENATED FATTY ACIDS AND AGENTS THAT INCREASE cAMP

#40 | 2011-04-28

US20110098322A1

Chemistry; metallurgy

PREPARATION OF NOVEL 1,3-SUBSTITUTED UREAS AS INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE

#41 | 2011-03-17

US20110065756A1

Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF OBESITY-RELATED DISEASES

#42 | 2011-01-27

US20110021448A1

Chemistry; metallurgy

Inhibitors for the soluble epoxide hydrolase

#43 | 2010-12-16

US20100317733A1

Human necessities

USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS

#44 | 2010-11-11

US20100286222A1

Human necessities

USE OF INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO SYNERGIZE ACTIVITY OF COX AND 5-LOX INHIBITORS

#45 | 2010-10-28

US20100275284A1

Chemistry; metallurgy

Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them

#46 | 2010-10-21

US20100267807A1

Human necessities

Alleviating neuropathic pain with EETs and sEH inhibitors

#47 | 2010-06-24

US20100160391A1

Chemistry; metallurgy

Substituted Aminopyridines as Fluorescent Reporters for Amide Hydrolases

#48 | 2010-03-25

US20100074852A1

Human necessities

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to treat conditions mediated by PBR, CB2, and NK2 receptors

#49 | 2009-12-31

US20090326039A1

Chemistry; metallurgy

Inhibitors for the soluble epoxide hydrolase

#50 | 2009-08-27

US20090216318A1

Chemistry; metallurgy

Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy

#51 | 2009-08-27

US20090215894A1

Human necessities

INHIBITION OF PHOSPHATASE ACTIVITY OF SOLUBLE EPOXIDE HYDROLASE AMINO TERMINUS AND USES THEREOF

#52 | 2009-01-15

US20090018092A1

Human necessities

Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and Epoxyeicosanoids

#53 | 2008-11-13

US20080279912A1

Human necessities

Use of Cis-Epoxyeicosatrienoic Acids And Inhibitors of Soluble Epoxide Hydrolase to Alleviate Eye Disorders

#54 | 2008-10-09

US20080249055A1

Human necessities

Use of sEH inhibitors as analgesics

#55 | 2008-08-07

US20080188554A1

Human necessities

METHODS OF TREATING AVIAN HYPERTENSION

#56 | 2007-09-27

US20070225283A1

Chemistry; metallurgy

Conformationally restricted urea inhibitors of soluble epoxide hydrolase

#57 | 2007-09-20

US20070218507A1

Chemistry; metallurgy

Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them

#58 | 2007-05-24

US20070117782A1

Human necessities

Inhibitors of epoxide hydrolases for the treatment of inflammation

#59 | 2007-02-13

US10264480

Isolated polypeptides and compositions from the venom of and methods of use

#60 | 2007-02-06

US10041859

Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them

#61 | 2006-11-30

US20060270609A1

Chemistry; metallurgy

Inhibitors for the soluble epoxide hydrolase

#62 | 2006-08-10

US20060178347A1

Human necessities

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

#63 | 2006-07-06

US20060148744A1

Human necessities

Use of cis-epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce damage from stroke

#64 | 2006-02-16

US20060035869A1

Human necessities

Inhibitors of epoxide hydrolases for the treatment of hypertension

#65 | 2005-12-22

US20050282767A1

Human necessities

Inhibitors of epoxide hydrolases for the treatment of hypertension

#66 | 2005-10-06

US20050222252A1

Human necessities

Use of cis-Epoxyeicosantrienoic acids and inhibitors of soluble epoxide hydrolase to reduce pulmonary infiltration by neutrophils

#67 | 2005-07-28

US20050164951A1

Chemistry; metallurgy

Inhibitors for the soluble epoxide hydrolase

#68 | 2005-02-03

US20050026844A1

Chemistry; metallurgy

Inhibitors for the soluble epoxide hydrolase

InventorID:

100204 ⎘